Gabelli Securities »

Catalyst Pharmaceutical Partners shares owned by Gabelli Securities

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0M 159k 31.43

More positions owned by Gabelli Securities

Electronic Arts Equity (EA)
Warner Bros Discovery Equity (WBD)
Chart Industries Equity (GTLS)
Txnm Energy Equity (TXNM)
Janus Henderson Group Equity
Gabelli Dividend & Income Tr Exchange Traded (GDV)
Kenvue Equity (KVUE)
Penumbra Equity (PEN)
Norfolk Southern Corp Equity (NSC)
Aes Corp Equity (AES)
Gdl Fund Exchange Traded (GDL)
Digitalbridge Group Equity (DBRG)
Webster Financial Corp Equity (WBS)
Roku Equity (ROKU)
Bio-techne Corp Equity (TECH)

View all positions for Gabelli Securities

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners